Use of Propofol as a Sedative Agent Versus Spinal Analgesia With Bupivacaine in External Cephalic Version

Condition(s) studied

Investigational drug(s) / intervention(s)

Sedation with propofol: Sedation with propofol

Spinal analgesia with bupivacaine: Spinal analgesia with bupivacaine

Study summary

External Cephalic Version (ECV) is a maneuver to modify fetal position in pregnant women with a non-cephalic presentation. Its objective is to achieve a cephalic presentation that allows for vaginal delivery with less risk than a vaginal breech delivery or a cesarean section. ECV is an effective technique to reduce the rate of cesarean sections and is recommended by the Spanish Society of Obstetrics and Gynecology (SEGO) and the World Health Organization (WHO) Cesarean Section Working Group. The WHO aims to reduce interventionism in childbirth globally and implement non-clinical measures to reduce the rate of unnecessary cesarean sections.

Despite Propofol is a sedative agent commonly used by anesthesiologist in countless ambulatory procedures in obstetric anaesthesia, it has been little studied in ECV, and its effect has not been compared with other commonly used agents such as remifentanil or spinal analgesia. The Obstetric Anesthesiology Section of the Spanish Society of Anesthesiology and Resuscitation recommends the use of locoregional analgesia in ECV.

Eligibility

Primary outcome measure(s)

• compare the success rate of external cephalic version — Up to 24 months.
  Number of external cephalic version when Propofol is used as a sedative agent or spinal analgesia.

Trial sites (1)

More Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia trials in Spain

Other trials for the same condition